0001209191-22-010074.txt : 20220216
0001209191-22-010074.hdr.sgml : 20220216
20220216080339
ACCESSION NUMBER: 0001209191-22-010074
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220214
FILED AS OF DATE: 20220216
DATE AS OF CHANGE: 20220216
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Stuart Nancy
CENTRAL INDEX KEY: 0001594774
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36310
FILM NUMBER: 22641546
MAIL ADDRESS:
STREET 1: 99 HAYDEN AVENUE, SUITE 500
CITY: LEXINGTON
STATE: MA
ZIP: 02421
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CONCERT PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001367920
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 65 HAYDEN AVENUE
STREET 2: SUITE 3000N
CITY: LEXINGTON
STATE: MA
ZIP: 02421
BUSINESS PHONE: 781-860-0045
MAIL ADDRESS:
STREET 1: 65 HAYDEN AVENUE
STREET 2: SUITE 3000N
CITY: LEXINGTON
STATE: MA
ZIP: 02421
FORMER COMPANY:
FORMER CONFORMED NAME: CONCERT PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20060628
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-02-14
0
0001367920
CONCERT PHARMACEUTICALS, INC.
CNCE
0001594774
Stuart Nancy
C/O CONCERT PHARMACEUTICALS, INC.
65 HAYDEN AVENUE, SUITE 3000N
LEXINGTON
MA
02421
0
1
0
0
Chief Operating Officer
Common Stock
2022-02-14
4
S
0
6049
3.08
D
284737
D
This sale was effected pursuant to a Rule 10b5-1 trading plan.
These shares were sold to satisfy tax obligations associated with the vesting of restricted stock units.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $3.00 to $3.18, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within such range.
/s/ Jeffrey A. Munsie, attorney-in-fact
2022-02-16